- Home
- BNR vs SCNX Comparison
BNR vs SCNX Comparison
Compare BNR & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- SCNX
- Stock Information
- Founded
- BNR 2014
- SCNX 2010
- Country
- BNR China
- SCNX United States
- Employees
- BNR N/A
- SCNX N/A
- Industry
- BNR Medical Specialities
- SCNX Other Pharmaceuticals
- Sector
- BNR Health Care
- SCNX Health Care
- Exchange
- BNR Nasdaq
- SCNX Nasdaq
- Market Cap
- BNR 29.1M
- SCNX 33.6M
- IPO Year
- BNR 2020
- SCNX 2020
- Fundamental
- Price
- BNR $3.10
- SCNX $0.87
- Analyst Decision
- BNR
- SCNX
- Analyst Count
- BNR 0
- SCNX 0
- Target Price
- BNR N/A
- SCNX N/A
- AVG Volume (30 Days)
- BNR 68.0K
- SCNX 76.0K
- Earning Date
- BNR 06-10-2025
- SCNX 05-12-2025
- Dividend Yield
- BNR N/A
- SCNX N/A
- EPS Growth
- BNR N/A
- SCNX N/A
- EPS
- BNR N/A
- SCNX N/A
- Revenue
- BNR $70,669,261.00
- SCNX $146,901.00
- Revenue This Year
- BNR $136.32
- SCNX N/A
- Revenue Next Year
- BNR N/A
- SCNX N/A
- P/E Ratio
- BNR N/A
- SCNX N/A
- Revenue Growth
- BNR N/A
- SCNX N/A
- 52 Week Low
- BNR $2.18
- SCNX $0.69
- 52 Week High
- BNR $7.90
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- BNR 51.73
- SCNX N/A
- Support Level
- BNR $2.99
- SCNX N/A
- Resistance Level
- BNR $3.45
- SCNX N/A
- Average True Range (ATR)
- BNR 0.34
- SCNX 0.00
- MACD
- BNR 0.10
- SCNX 0.00
- Stochastic Oscillator
- BNR 70.59
- SCNX 0.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.